- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT04164082
Тестирование добавления противоракового препарата пембролизумаб к обычной внутрипузырной химиотерапии (гемцитабин) для лечения БЦЖ-резистентного немышечно-инвазивного рака мочевого пузыря
Испытание фазы II гемцитабина внутрипузырно и MK-3475 (пембролизумаб) в лечении пациентов с БЦЖ-резистентным неинвазивным раком мочевого пузыря
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not respond to Bacillus Calmette-Guerin (BCG) treatment. Chemotherapy drugs, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the patient's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding pembrolizumab to gemcitabine may delay the return of BCG-unresponsive bladder cancer for longer period compared to gemcitabine alone.
Обзор исследования
Статус
Условия
Подробное описание
PRIMARY OBJECTIVES:
I. Estimate the 6-month complete response rate of treatment with intravesical gemcitabine hydrochloride (gemcitabine) in combination with MK-3475 (pembrolizumab) in patients with Bacillus Calmette-Guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) that have a carcinoma in situ (CIS) component.
II. Estimate the 18 month event-free survival (EFS) rate for all patients with BCG-unresponsive NMIBC receiving intravesical gemcitabine in combination with MK-3475 (pembrolizumab).
SECONDARY OBJECTIVES:
I. To characterize the safety profile of the combination of intravesical gemcitabine with MK-3475 (pembrolizumab) with BCG-unresponsive NMIBC (CIS or high grade Ta and T1 with or without a CIS component).
II. To estimate progression-free survival (PFS) of patients with BCG-unresponsive NMIBC treated with intravesical gemcitabine in combination with MK-3475 (pembrolizumab).
III. To estimate overall survival (OS) of patients with BCG-unresponsive NMIBC treated with intravesical gemcitabine in combination with MK-3475 (pembrolizumab).
IV. To estimate cystectomy-free survival of patients with BCG-unresponsive NMIBC treated with intravesical gemcitabine in combination with MK-3475 (pembrolizumab).
V. To estimate recurrence-free survival (RFS) for patients with a CIS component only and those without a CIS component.
EXPLORATORY OBJECTIVES:
I. To assess correlation between tumor mutation burden (TMB) and EFS and 6-month complete response (CR) rate.
II. To assess correlation between specific genomic alterations (single nucleotide variant [SNV] and copy number gains/loss) and EFS and 6-month complete response rate.
III. To assess correlation between APOBEC mutational signature and EFS and 6-month complete response rate.
IV. To assess correlation between immune gene signatures (IGS) and EFS and 6-month complete response rate.
V. To assess correlation between PD-L1 ribonucleic acid (RNA) levels and EFS and 6-month complete response rate.
VI. To assess correlation between RNA molecular subtype and EFS and 6-month complete response rate.
VII. To assess correlation between intratumoral T-cell receptor (TCR) clonality and EFS and 6-month complete response rate.
VIII. To assess correlation between changes in peripheral blood TCR clonality and EFS and 6-month complete response rate.
IX. To assess EFS in patients with urine cell free deoxyribonucleic acid (DNA) (cfDNA) + versus (vs.) patients with cfDNA.
OUTLINE:
INDUCTION: Patients receive pembrolizumab intravenously (IV) over 25-40 minutes on day 1 of cycles 1-4. Patients also receive gemcitabine hydrochloride intravesically on days 1, 8 and 15 of cycles 1 and 2. Treatment repeats every 3 weeks for 4 cycles in the absence of disease progression or unacceptable toxicity.
MAINTENANCE: Beginning cycle 5, patients with no evidence of disease after induction receive pembrolizumab IV over 25-40 minutes and gemcitabine intravesically on day 1 of each cycle. Treatment repeats every 3 weeks for 12 cycles in the absence of disease progression or unacceptable toxicity.
Additionally, patients with T1 tumors undergo a re-staging transurethral resection of bladder tumor (TURBT) within 60 days of registration. Patients also undergo urine and blood sample collection, bladder biopsy, cystoscopy, computed tomography (CT) and magnetic resonance imaging (MRI) throughout the study.
After completion of study treatment, patients with evidence of disease (recurrence or progression) or stop study treatment to receive non-protocol treatment during induction are followed up every 6 months for 5 years. Patients who go off treatment due to any reason other than recurrence/progression or receiving subsequent non-protocol treatment during induction will go to clinical follow-up until evidence of disease progression/recurrence. Thereafter, patients are followed up every 6 months until 5 years from registration. Patients who complete scheduled maintenance treatment according to protocol therapy are followed up every 3 months for 2 years and then every 6 months for 3 years until disease progression/recurrence or receiving subsequent non-protocol treatment. Thereafter, patients are followed up every 6 months until 5 years from registration. Patients who have evidence of disease during maintenance therapy are followed up every 6 months until 5 years from registration.
Тип исследования
Регистрация (Оцененный)
Фаза
- Фаза 2
Контакты и местонахождение
Места учебы
-
-
-
Tamuning, Гуам, 96913
- FHP Health Center-Guam
-
-
-
-
-
Bayamón, Пуэрто-Рико, 00959-5060
- Cancer Center-Metro Medical Center Bayamon
-
Bayamón, Пуэрто-Рико, 00961
- Puerto Rico Hematology Oncology Group
-
Caguas, Пуэрто-Рико, 00726
- HIMA San Pablo Oncologic Hospital
-
Manati, Пуэрто-Рико, 00674
- Doctors Cancer Center
-
Ponce, Пуэрто-Рико, 00716
- Instituto Oncologia Moderna Ponce
-
San Juan, Пуэрто-Рико, 00917
- San Juan Community Oncology Group
-
San Juan, Пуэрто-Рико, 00927
- Centro Comprensivo de Cancer de UPR
-
San Juan, Пуэрто-Рико, 00936
- San Juan City Hospital
-
-
-
-
Alabama
-
Birmingham, Alabama, Соединенные Штаты, 35233
- University of Alabama at Birmingham Cancer Center
-
-
Alaska
-
Anchorage, Alaska, Соединенные Штаты, 98508
- Anchorage Associates in Radiation Medicine
-
Anchorage, Alaska, Соединенные Штаты, 99508
- Alaska Breast Care and Surgery LLC
-
Anchorage, Alaska, Соединенные Штаты, 99508
- Alaska Oncology and Hematology LLC
-
Anchorage, Alaska, Соединенные Штаты, 99508
- Alaska Women's Cancer Care
-
Anchorage, Alaska, Соединенные Штаты, 99508
- Anchorage Oncology Centre
-
Anchorage, Alaska, Соединенные Штаты, 99508
- Katmai Oncology Group
-
Anchorage, Alaska, Соединенные Штаты, 99508
- Providence Alaska Medical Center
-
Anchorage, Alaska, Соединенные Штаты, 99504
- Anchorage Radiation Therapy Center
-
Fairbanks, Alaska, Соединенные Штаты, 99701
- Fairbanks Memorial Hospital
-
-
Arizona
-
Phoenix, Arizona, Соединенные Штаты, 85054
- Mayo Clinic Hospital in Arizona
-
Phoenix, Arizona, Соединенные Штаты, 85004
- Cancer Center at Saint Joseph's
-
Scottsdale, Arizona, Соединенные Штаты, 85259
- Mayo Clinic in Arizona
-
-
Arkansas
-
Fort Smith, Arkansas, Соединенные Штаты, 72903
- Mercy Hospital Fort Smith
-
-
California
-
Burbank, California, Соединенные Штаты, 91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Los Angeles, California, Соединенные Штаты, 90048
- Cedars-Sinai Medical Center
-
Sacramento, California, Соединенные Штаты, 95817
- University of California Davis Comprehensive Cancer Center
-
-
Colorado
-
Aurora, Colorado, Соединенные Штаты, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Aurora, Colorado, Соединенные Штаты, 80012
- The Medical Center of Aurora
-
Boulder, Colorado, Соединенные Штаты, 80303
- Boulder Community Foothills Hospital
-
Boulder, Colorado, Соединенные Штаты, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Centennial, Colorado, Соединенные Штаты, 80112
- Rocky Mountain Cancer Centers - Centennial
-
Denver, Colorado, Соединенные Штаты, 80218
- Presbyterian - Saint Lukes Medical Center - Health One
-
Denver, Colorado, Соединенные Штаты, 80220
- Rose Medical Center
-
Denver, Colorado, Соединенные Штаты, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Соединенные Штаты, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Соединенные Штаты, 80218
- Colorado Blood Cancer Institute
-
Denver, Colorado, Соединенные Штаты, 80204
- Cancer Center of Colorado at Sloan's Lake
-
Denver, Colorado, Соединенные Штаты, 80209
- The Women's Imaging Center
-
Denver, Colorado, Соединенные Штаты, 80206
- National Jewish Health-Main Campus
-
Denver, Colorado, Соединенные Штаты, 80220
- Western Surgical Care
-
Denver, Colorado, Соединенные Штаты, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Englewood, Colorado, Соединенные Штаты, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, Соединенные Штаты, 80113
- Swedish Medical Center
-
Englewood, Colorado, Соединенные Штаты, 80113
- Rocky Mountain Cancer Centers - Swedish
-
Englewood, Colorado, Соединенные Штаты, 80113
- The Melanoma and Skin Cancer Institute
-
Golden, Colorado, Соединенные Штаты, 80401
- National Jewish Health-Western Hematology Oncology
-
Grand Junction, Colorado, Соединенные Штаты, 81501
- Saint Mary's Hospital and Regional Medical Center
-
Greeley, Colorado, Соединенные Штаты, 80631
- Banner North Colorado Medical Center
-
Lafayette, Colorado, Соединенные Штаты, 80026
- Good Samaritan Hospital - Cancer Centers of Colorado
-
Lakewood, Colorado, Соединенные Штаты, 80228
- Rocky Mountain Cancer Centers-Lakewood
-
Littleton, Colorado, Соединенные Штаты, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree, Colorado, Соединенные Штаты, 80124
- Sky Ridge Medical Center
-
Lone Tree, Colorado, Соединенные Штаты, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Loveland, Colorado, Соединенные Штаты, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Thornton, Colorado, Соединенные Штаты, 80260
- Rocky Mountain Cancer Centers-Thornton
-
Thornton, Colorado, Соединенные Штаты, 80260
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge, Colorado, Соединенные Штаты, 80401
- Intermountain Health Lutheran Hospital
-
-
District of Columbia
-
Washington D.C., District of Columbia, Соединенные Штаты, 20010
- MedStar Washington Hospital Center
-
Washington D.C., District of Columbia, Соединенные Штаты, 20007
- MedStar Georgetown University Hospital
-
-
Florida
-
Fort Lauderdale, Florida, Соединенные Штаты, 33308
- Holy Cross Hospital
-
Gainesville, Florida, Соединенные Штаты, 32610
- UF Health Cancer Institute - Gainesville
-
-
Hawaii
-
Honolulu, Hawaii, Соединенные Штаты, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Соединенные Штаты, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, Соединенные Штаты, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Соединенные Штаты, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, Соединенные Штаты, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Соединенные Штаты, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, Соединенные Штаты, 96817
- Hawaii Cancer Care Inc-Liliha
-
Honolulu, Hawaii, Соединенные Штаты, 96817
- Kuakini Medical Center
-
Honolulu, Hawaii, Соединенные Штаты, 96817
- Queen's Cancer Center - Kuakini
-
Honolulu, Hawaii, Соединенные Штаты, 96826
- Kapiolani Medical Center for Women and Children
-
Honolulu, Hawaii, Соединенные Штаты, 96813
- Island Urology
-
Honolulu, Hawaii, Соединенные Штаты, 96817
- Hawaii Diagnostic Radiology Services LLC
-
Kahului, Hawaii, Соединенные Штаты, 96732
- Straub Medical Center - Kahului Clinic
-
Kailua, Hawaii, Соединенные Штаты, 96734
- Castle Medical Center
-
Lihue, Hawaii, Соединенные Штаты, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Соединенные Штаты, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, Соединенные Штаты, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, Соединенные Штаты, 96701
- Queen's Cancer Center - Pearlridge
-
‘Aiea, Hawaii, Соединенные Штаты, 96701
- The Cancer Center of Hawaii-Pali Momi
-
‘Ewa Beach, Hawaii, Соединенные Штаты, 96706
- The Queen's Medical Center - West Oahu
-
-
Idaho
-
Boise, Idaho, Соединенные Штаты, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Соединенные Штаты, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Соединенные Штаты, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Соединенные Штаты, 83814
- Kootenai Health - Coeur d'Alene
-
Emmett, Idaho, Соединенные Штаты, 83617
- Walter Knox Memorial Hospital
-
Fruitland, Idaho, Соединенные Штаты, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Соединенные Штаты, 83642
- Idaho Urologic Institute-Meridian
-
Meridian, Idaho, Соединенные Штаты, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Соединенные Штаты, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Соединенные Штаты, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Соединенные Штаты, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Соединенные Штаты, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Соединенные Штаты, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Alton, Illinois, Соединенные Штаты, 62002
- OSF Saint Anthony's Health Center
-
Bloomington, Illinois, Соединенные Штаты, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Соединенные Штаты, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, Соединенные Штаты, 62902
- Memorial Hospital of Carbondale
-
Carterville, Illinois, Соединенные Штаты, 62918
- SIH Cancer Institute
-
Carthage, Illinois, Соединенные Штаты, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Соединенные Штаты, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Соединенные Штаты, 60612
- Rush MD Anderson Cancer Center
-
Decatur, Illinois, Соединенные Штаты, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Соединенные Штаты, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon, Illinois, Соединенные Штаты, 61021
- Illinois CancerCare-Dixon
-
Effingham, Illinois, Соединенные Штаты, 62401
- Crossroads Cancer Center
-
Eureka, Illinois, Соединенные Штаты, 61530
- Illinois CancerCare-Eureka
-
Galesburg, Illinois, Соединенные Штаты, 61401
- Western Illinois Cancer Treatment Center
-
Galesburg, Illinois, Соединенные Штаты, 61401
- Illinois CancerCare-Galesburg
-
Kewanee, Illinois, Соединенные Штаты, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, Соединенные Штаты, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Соединенные Штаты, 60153
- Loyola University Medical Center
-
Melrose Park, Illinois, Соединенные Штаты, 60160
- Marjorie Weinberg Cancer Center at Loyola-Gottlieb
-
Mount Vernon, Illinois, Соединенные Штаты, 62864
- SSM Health Good Samaritan
-
O'Fallon, Illinois, Соединенные Штаты, 62269
- Cancer Care Center of O'Fallon
-
Ottawa, Illinois, Соединенные Штаты, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, Соединенные Штаты, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Соединенные Штаты, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Соединенные Штаты, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Соединенные Штаты, 61354
- Illinois CancerCare-Peru
-
Peru, Illinois, Соединенные Штаты, 61354
- Valley Radiation Oncology
-
Princeton, Illinois, Соединенные Штаты, 61356
- Illinois CancerCare-Princeton
-
Springfield, Illinois, Соединенные Штаты, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Соединенные Штаты, 62702
- Springfield Clinic
-
Springfield, Illinois, Соединенные Штаты, 62781
- Springfield Memorial Hospital
-
Swansea, Illinois, Соединенные Штаты, 62226
- Southwest Illinois Health Services LLP
-
Washington, Illinois, Соединенные Штаты, 61571
- Illinois CancerCare - Washington
-
-
Indiana
-
Richmond, Indiana, Соединенные Штаты, 47374
- Reid Health
-
South Bend, Indiana, Соединенные Штаты, 46601
- Memorial Hospital of South Bend
-
-
Kansas
-
Garden City, Kansas, Соединенные Штаты, 67846
- Central Care Cancer Center - Garden City
-
Great Bend, Kansas, Соединенные Штаты, 67530
- Central Care Cancer Center - Great Bend
-
Kansas City, Kansas, Соединенные Штаты, 66160
- University of Kansas Cancer Center
-
Overland Park, Kansas, Соединенные Штаты, 66211
- University of Kansas Hospital-Indian Creek Campus
-
Westwood, Kansas, Соединенные Штаты, 66205
- University of Kansas Hospital-Westwood Cancer Center
-
-
Kentucky
-
Lexington, Kentucky, Соединенные Штаты, 40536
- University of Kentucky/Markey Cancer Center
-
-
Louisiana
-
Baton Rouge, Louisiana, Соединенные Штаты, 70809
- Louisiana Hematology Oncology Associates LLC
-
Baton Rouge, Louisiana, Соединенные Штаты, 70809
- Mary Bird Perkins Cancer Center
-
Metairie, Louisiana, Соединенные Штаты, 70006
- East Jefferson General Hospital
-
Metairie, Louisiana, Соединенные Штаты, 70006
- LSU Healthcare Network / Metairie Multi-Specialty Clinic
-
Metairie, Louisiana, Соединенные Штаты, 70002
- Mary Bird Perkins Cancer Center - Metairie
-
New Orleans, Louisiana, Соединенные Штаты, 70112
- University Medical Center New Orleans
-
New Orleans, Louisiana, Соединенные Штаты, 70112
- Louisiana State University Health Science Center
-
New Orleans, Louisiana, Соединенные Штаты, 70115
- Touro Infirmary
-
-
Maryland
-
Glen Burnie, Maryland, Соединенные Штаты, 21061
- UM Baltimore Washington Medical Center/Tate Cancer Center
-
-
Massachusetts
-
Lowell, Massachusetts, Соединенные Штаты, 01854
- Lowell General Hospital
-
Springfield, Massachusetts, Соединенные Штаты, 01104
- Mercy Medical Center
-
-
Michigan
-
Adrian, Michigan, Соединенные Штаты, 49221
- Hickman Cancer Center
-
Ann Arbor, Michigan, Соединенные Штаты, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek, Michigan, Соединенные Штаты, 49017
- Bronson Battle Creek
-
Brighton, Michigan, Соединенные Штаты, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Соединенные Штаты, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, Соединенные Штаты, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Соединенные Штаты, 48188
- Trinity Health Medical Center - Canton
-
Caro, Michigan, Соединенные Штаты, 48723
- Caro Cancer Center
-
Chelsea, Michigan, Соединенные Штаты, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Соединенные Штаты, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Соединенные Штаты, 48346
- Hematology Oncology Consultants-Clarkston
-
Clarkston, Michigan, Соединенные Штаты, 48346
- Newland Medical Associates-Clarkston
-
Detroit, Michigan, Соединенные Штаты, 48236
- Henry Ford Health Saint John Hospital
-
East China Township, Michigan, Соединенные Штаты, 48054
- Henry Ford River District Hospital
-
Flint, Michigan, Соединенные Штаты, 48503
- Hurley Medical Center
-
Flint, Michigan, Соединенные Штаты, 48503
- Genesee Hematology Oncology PC
-
Flint, Michigan, Соединенные Штаты, 48503
- Genesys Hurley Cancer Institute
-
Flint, Michigan, Соединенные Штаты, 48503
- Cancer Hematology Centers - Flint
-
Grand Rapids, Michigan, Соединенные Штаты, 49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids, Michigan, Соединенные Штаты, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Grand Rapids, Michigan, Соединенные Штаты, 49503
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
-
Grosse Pointe Woods, Michigan, Соединенные Штаты, 48236
- Henry Ford Saint John Hospital - Academic
-
Grosse Pointe Woods, Michigan, Соединенные Штаты, 48236
- Henry Ford Saint John Hospital - Breast
-
Grosse Pointe Woods, Michigan, Соединенные Штаты, 48236
- Henry Ford Saint John Hospital - Van Elslander
-
Kalamazoo, Michigan, Соединенные Штаты, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Соединенные Штаты, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Соединенные Штаты, 49009
- Beacon Kalamazoo Cancer Center
-
Kalamazoo, Michigan, Соединенные Штаты, 49048
- Beacon Kalamazoo
-
Lansing, Michigan, Соединенные Штаты, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Соединенные Штаты, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Livonia, Michigan, Соединенные Штаты, 48154
- Hope Cancer Clinic
-
Macomb, Michigan, Соединенные Штаты, 48044
- Henry Ford Warren Hospital - Breast Macomb
-
Macomb, Michigan, Соединенные Штаты, 48044
- Henry Ford Saint John Hospital - Macomb Medical
-
Marlette, Michigan, Соединенные Штаты, 48453
- Saint Mary's Oncology/Hematology Associates of Marlette
-
Monroe, Michigan, Соединенные Штаты, 48162
- Toledo Clinic Cancer Centers-Monroe
-
Muskegon, Michigan, Соединенные Штаты, 49444
- Trinity Health Muskegon Hospital
-
Niles, Michigan, Соединенные Штаты, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Norton Shores, Michigan, Соединенные Штаты, 49444
- Cancer and Hematology Centers of Western Michigan - Norton Shores
-
Pontiac, Michigan, Соединенные Штаты, 48341
- Hope Cancer Center
-
Pontiac, Michigan, Соединенные Штаты, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, Соединенные Штаты, 48341
- Michigan Healthcare Professionals Pontiac
-
Pontiac, Michigan, Соединенные Штаты, 48341
- Trinity Health IHA Medical Group-Alice Gustafson Center
-
Reed City, Michigan, Соединенные Штаты, 49677
- Corewell Health Reed City Hospital
-
Rochester Hills, Michigan, Соединенные Штаты, 48309
- Henry Ford Rochester Hospital
-
Saginaw, Michigan, Соединенные Штаты, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Соединенные Штаты, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, Соединенные Штаты, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, Соединенные Штаты, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Sterling Heights, Michigan, Соединенные Штаты, 48312
- Bhadresh Nayak MD PC-Sterling Heights
-
Tawas City, Michigan, Соединенные Штаты, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, Соединенные Штаты, 49684
- Munson Medical Center
-
Warren, Michigan, Соединенные Штаты, 48088
- Advanced Breast Care Center PLLC
-
Warren, Michigan, Соединенные Штаты, 48093
- Macomb Hematology Oncology PC
-
Warren, Michigan, Соединенные Штаты, 48093
- Henry Ford Madison Heights Hospital - Breast
-
Warren, Michigan, Соединенные Штаты, 48093
- Henry Ford Health Warren Hospital
-
Warren, Michigan, Соединенные Штаты, 48093
- Henry Ford Warren Hospital - GLCMS
-
West Branch, Michigan, Соединенные Штаты, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Wyoming, Michigan, Соединенные Штаты, 49519
- University of Michigan Health - West
-
Ypsilanti, Michigan, Соединенные Штаты, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
Ypsilanti, Michigan, Соединенные Штаты, 48106
- Huron Gastroenterology PC
-
-
Minnesota
-
Burnsville, Minnesota, Соединенные Штаты, 55337
- Fairview Ridges Hospital
-
Burnsville, Minnesota, Соединенные Штаты, 55337
- Minnesota Oncology - Burnsville
-
Cambridge, Minnesota, Соединенные Штаты, 55008
- Cambridge Medical Center
-
Coon Rapids, Minnesota, Соединенные Штаты, 55433
- Mercy Hospital
-
Edina, Minnesota, Соединенные Штаты, 55435
- Fairview Southdale Hospital
-
Fridley, Minnesota, Соединенные Штаты, 55432
- Unity Hospital
-
Maple Grove, Minnesota, Соединенные Штаты, 55369
- Fairview Clinics and Surgery Center Maple Grove
-
Maplewood, Minnesota, Соединенные Штаты, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Соединенные Штаты, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Соединенные Штаты, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Соединенные Штаты, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Соединенные Штаты, 55454
- Health Partners Inc
-
Monticello, Minnesota, Соединенные Штаты, 55362
- Monticello Cancer Center
-
New Ulm, Minnesota, Соединенные Штаты, 56073
- New Ulm Medical Center
-
Princeton, Minnesota, Соединенные Штаты, 55371
- Fairview Northland Medical Center
-
Robbinsdale, Minnesota, Соединенные Штаты, 55422
- North Memorial Medical Health Center
-
Saint Louis Park, Minnesota, Соединенные Штаты, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Соединенные Штаты, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Соединенные Штаты, 55102
- United Hospital
-
Shakopee, Minnesota, Соединенные Штаты, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Соединенные Штаты, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Соединенные Штаты, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Соединенные Штаты, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Соединенные Штаты, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
Wyoming, Minnesota, Соединенные Штаты, 55092
- Fairview Lakes Medical Center
-
-
Missouri
-
Ballwin, Missouri, Соединенные Штаты, 63011
- Mercy Oncology and Hematology - Clayton-Clarkson
-
Bolivar, Missouri, Соединенные Штаты, 65613
- Central Care Cancer Center - Bolivar
-
Branson, Missouri, Соединенные Штаты, 65616
- Cox Cancer Center Branson
-
Cape Girardeau, Missouri, Соединенные Штаты, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Соединенные Штаты, 63703
- Mercy Cancer Center - Cape Girardeau
-
Chesterfield, Missouri, Соединенные Штаты, 63017
- Saint Luke's Hospital
-
Columbia, Missouri, Соединенные Штаты, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Farmington, Missouri, Соединенные Штаты, 63640
- Parkland Health Center - Farmington
-
Jefferson City, Missouri, Соединенные Штаты, 65109
- MU Health Care Goldschmidt Cancer Center
-
Joplin, Missouri, Соединенные Штаты, 64804
- Freeman Health System
-
Joplin, Missouri, Соединенные Штаты, 64804
- Mercy Hospital Joplin
-
Rolla, Missouri, Соединенные Штаты, 65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Rolla, Missouri, Соединенные Штаты, 65401
- Phelps Health Delbert Day Cancer Institute
-
Saint Joseph, Missouri, Соединенные Штаты, 64506
- Heartland Regional Medical Center
-
Sainte Genevieve, Missouri, Соединенные Штаты, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, Соединенные Штаты, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Соединенные Штаты, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, Соединенные Штаты, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Соединенные Штаты, 63109
- Mercy Infusion Center - Chippewa
-
St Louis, Missouri, Соединенные Штаты, 63141
- Mercy Hospital Saint Louis
-
St Louis, Missouri, Соединенные Штаты, 63128
- Mercy Hospital South
-
Sullivan, Missouri, Соединенные Штаты, 63080
- Missouri Baptist Sullivan Hospital
-
Washington, Missouri, Соединенные Штаты, 63090
- Mercy Hospital Washington
-
-
Montana
-
Anaconda, Montana, Соединенные Штаты, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Соединенные Штаты, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Соединенные Штаты, 59101
- Saint Vincent Healthcare
-
Billings, Montana, Соединенные Штаты, 59102
- Saint Vincent Frontier Cancer Center
-
Bozeman, Montana, Соединенные Штаты, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, Соединенные Штаты, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, Соединенные Штаты, 59405
- Great Falls Clinic
-
Great Falls, Montana, Соединенные Штаты, 59405
- Benefis Sletten Cancer Institute
-
Kalispell, Montana, Соединенные Штаты, 59901
- Logan Health Medical Center
-
Missoula, Montana, Соединенные Штаты, 59802
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, Соединенные Штаты, 59804
- Community Medical Center
-
-
New Hampshire
-
Lebanon, New Hampshire, Соединенные Штаты, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
-
New Jersey
-
Basking Ridge, New Jersey, Соединенные Штаты, 07920
- Memorial Sloan Kettering Basking Ridge
-
Hackensack, New Jersey, Соединенные Штаты, 07601
- Hackensack University Medical Center
-
Middletown, New Jersey, Соединенные Штаты, 07748
- Memorial Sloan Kettering Monmouth
-
Montvale, New Jersey, Соединенные Штаты, 07645
- Memorial Sloan Kettering Bergen
-
Paramus, New Jersey, Соединенные Штаты, 07652
- The Valley Hospital - Luckow Pavilion
-
Ridgewood, New Jersey, Соединенные Штаты, 07450
- Neurosurgeons of New Jersey-Ridgewood
-
Ridgewood, New Jersey, Соединенные Штаты, 07450
- Valley Health System Ridgewood Campus
-
Westwood, New Jersey, Соединенные Штаты, 07675
- Valley Health System-Hematology/Oncology
-
-
New York
-
Commack, New York, Соединенные Штаты, 11725
- Memorial Sloan Kettering Commack
-
Elmira, New York, Соединенные Штаты, 14905
- Arnot Ogden Medical Center/Falck Cancer Center
-
Flushing, New York, Соединенные Штаты, 11355
- The New York Hospital Medical Center of Queens
-
Harrison, New York, Соединенные Штаты, 10604
- Memorial Sloan Kettering Westchester
-
New York, New York, Соединенные Штаты, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, Соединенные Штаты, 10065
- NYP/Weill Cornell Medical Center
-
Stony Brook, New York, Соединенные Штаты, 11794
- Stony Brook University Medical Center
-
Uniondale, New York, Соединенные Штаты, 11553
- Memorial Sloan Kettering Nassau
-
-
North Carolina
-
Chapel Hill, North Carolina, Соединенные Штаты, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Hillsborough, North Carolina, Соединенные Штаты, 27278
- University of North Carolina-Hillsborough Campus
-
-
Ohio
-
Beavercreek, Ohio, Соединенные Штаты, 45431
- Indu and Raj Soin Medical Center
-
Boardman, Ohio, Соединенные Штаты, 44512
- Saint Elizabeth Boardman Hospital
-
Centerville, Ohio, Соединенные Штаты, 45459
- Miami Valley Hospital South
-
Centerville, Ohio, Соединенные Штаты, 45459
- Dayton Physicians LLC-Miami Valley South
-
Cincinnati, Ohio, Соединенные Штаты, 45236
- Oncology Hematology Care Inc-Kenwood
-
Dayton, Ohio, Соединенные Штаты, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Соединенные Штаты, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Соединенные Штаты, 45415
- Dayton Physician LLC - Englewood
-
Findlay, Ohio, Соединенные Штаты, 45840
- Blanchard Valley Hospital
-
Findlay, Ohio, Соединенные Штаты, 45840
- Armes Family Cancer Center
-
Findlay, Ohio, Соединенные Штаты, 45840
- Orion Cancer Care
-
Franklin, Ohio, Соединенные Штаты, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Franklin, Ohio, Соединенные Штаты, 45005
- Dayton Physicians LLC-Atrium
-
Greenville, Ohio, Соединенные Штаты, 45331
- Wayne Hospital
-
Greenville, Ohio, Соединенные Штаты, 45331
- Dayton Physicians LLC-Wayne
-
Kettering, Ohio, Соединенные Штаты, 45429
- Kettering Medical Center
-
Kettering, Ohio, Соединенные Штаты, 45409
- Greater Dayton Cancer Center
-
Kettering, Ohio, Соединенные Штаты, 45420
- First Dayton Cancer Care
-
Perrysburg, Ohio, Соединенные Штаты, 43551
- Mercy Health - Perrysburg Hospital
-
Springfield, Ohio, Соединенные Штаты, 45504
- Springfield Regional Cancer Center
-
Springfield, Ohio, Соединенные Штаты, 45504
- Springfield Regional Medical Center
-
Toledo, Ohio, Соединенные Штаты, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, Соединенные Штаты, 43623
- Toledo Clinic Cancer Centers-Toledo
-
Troy, Ohio, Соединенные Штаты, 45373
- Upper Valley Medical Center
-
Troy, Ohio, Соединенные Штаты, 45373
- Dayton Physicians LLC - Troy
-
Warren, Ohio, Соединенные Штаты, 44484
- Saint Joseph Warren Hospital
-
Youngstown, Ohio, Соединенные Штаты, 44501
- Saint Elizabeth Youngstown Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Соединенные Штаты, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Соединенные Штаты, 73120
- Mercy Hospital Oklahoma City
-
-
Oregon
-
Baker City, Oregon, Соединенные Штаты, 97814
- Saint Alphonsus Cancer Care Center-Baker City
-
Bend, Oregon, Соединенные Штаты, 97701
- Saint Charles Health System
-
Clackamas, Oregon, Соединенные Штаты, 97015
- Clackamas Radiation Oncology Center
-
Clackamas, Oregon, Соединенные Штаты, 97015
- Providence Cancer Institute Clackamas Clinic
-
Coos Bay, Oregon, Соединенные Штаты, 97420
- Bay Area Hospital
-
Newberg, Oregon, Соединенные Штаты, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Соединенные Штаты, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Portland, Oregon, Соединенные Штаты, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Соединенные Штаты, 97225
- Providence Saint Vincent Medical Center
-
Redmond, Oregon, Соединенные Штаты, 97756
- Saint Charles Health System-Redmond
-
-
Pennsylvania
-
Allentown, Pennsylvania, Соединенные Штаты, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Bethlehem, Pennsylvania, Соединенные Штаты, 18017
- Lehigh Valley Hospital - Muhlenberg
-
East Stroudsburg, Pennsylvania, Соединенные Штаты, 18301
- Pocono Medical Center
-
Hazleton, Pennsylvania, Соединенные Штаты, 18201
- Lehigh Valley Hospital-Hazleton
-
-
South Carolina
-
Charleston, South Carolina, Соединенные Штаты, 29401
- Ralph H Johnson VA Medical Center
-
Gaffney, South Carolina, Соединенные Штаты, 29341
- Gibbs Cancer Center-Gaffney
-
Greer, South Carolina, Соединенные Штаты, 29651
- Gibbs Cancer Center-Pelham
-
Spartanburg, South Carolina, Соединенные Штаты, 29303
- Spartanburg Medical Center
-
Spartanburg, South Carolina, Соединенные Штаты, 29307
- Spartanburg Medical Center - Mary Black Campus
-
Spartanburg, South Carolina, Соединенные Штаты, 29303
- North Grove Medical Park
-
Union, South Carolina, Соединенные Штаты, 29379
- SMC Center for Hematology Oncology Union
-
-
Texas
-
Galveston, Texas, Соединенные Штаты, 77555-0565
- University of Texas Medical Branch
-
Houston, Texas, Соединенные Штаты, 77030
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
-
League City, Texas, Соединенные Штаты, 77573
- UTMB Cancer Center at Victory Lakes
-
San Antonio, Texas, Соединенные Штаты, 78229
- University of Texas Health Science Center at San Antonio
-
San Antonio, Texas, Соединенные Штаты, 78229
- Audie L Murphy VA Hospital
-
-
Utah
-
American Fork, Utah, Соединенные Штаты, 84003
- American Fork Hospital / Huntsman Intermountain Cancer Center
-
Cedar City, Utah, Соединенные Штаты, 84720
- Sandra L Maxwell Cancer Center
-
Logan, Utah, Соединенные Штаты, 84321
- Logan Regional Hospital
-
Murray, Utah, Соединенные Штаты, 84107
- Intermountain Medical Center
-
Ogden, Utah, Соединенные Штаты, 84403
- McKay-Dee Hospital Center
-
Provo, Utah, Соединенные Штаты, 84604
- Utah Valley Regional Medical Center
-
Riverton, Utah, Соединенные Штаты, 84065
- Riverton Hospital
-
Salt Lake City, Utah, Соединенные Штаты, 84106
- Utah Cancer Specialists-Salt Lake City
-
Salt Lake City, Utah, Соединенные Штаты, 84143
- LDS Hospital
-
St. George, Utah, Соединенные Штаты, 84770
- Saint George Regional Medical Center
-
-
Washington
-
Aberdeen, Washington, Соединенные Штаты, 98520
- Providence Regional Cancer System-Aberdeen
-
Auburn, Washington, Соединенные Штаты, 98001
- MultiCare Auburn Medical Center
-
Bellingham, Washington, Соединенные Штаты, 98225
- PeaceHealth Saint Joseph Medical Center
-
Centralia, Washington, Соединенные Штаты, 98531
- Providence Regional Cancer System-Centralia
-
Edmonds, Washington, Соединенные Штаты, 98026
- Swedish Cancer Institute-Edmonds
-
Everett, Washington, Соединенные Штаты, 98201
- Providence Regional Cancer Partnership
-
Gig Harbor, Washington, Соединенные Штаты, 98335
- MultiCare Gig Harbor Medical Park
-
Issaquah, Washington, Соединенные Штаты, 98029
- Swedish Cancer Institute-Issaquah
-
Kennewick, Washington, Соединенные Штаты, 99336
- Kadlec Clinic Hematology and Oncology
-
Lacey, Washington, Соединенные Штаты, 98503
- Providence Regional Cancer System-Lacey
-
Longview, Washington, Соединенные Штаты, 98632
- PeaceHealth Saint John Medical Center
-
Port Townsend, Washington, Соединенные Штаты, 98368
- Jefferson Healthcare
-
Puyallup, Washington, Соединенные Штаты, 98372
- MultiCare Good Samaritan Hospital
-
Seattle, Washington, Соединенные Штаты, 98107
- Swedish Medical Center-Ballard Campus
-
Seattle, Washington, Соединенные Штаты, 98122
- Swedish Medical Center-First Hill
-
Seattle, Washington, Соединенные Штаты, 98104
- Pacific Gynecology Specialists
-
Seattle, Washington, Соединенные Штаты, 98122-5711
- Swedish Medical Center-Cherry Hill
-
Sedro-Woolley, Washington, Соединенные Штаты, 98284
- PeaceHealth United General Medical Center
-
Shelton, Washington, Соединенные Штаты, 98584
- Providence Regional Cancer System-Shelton
-
Spokane, Washington, Соединенные Штаты, 99204
- MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
-
Spokane, Washington, Соединенные Штаты, 99218
- MultiCare Deaconess Cancer and Blood Specialty Center - North
-
Spokane Valley, Washington, Соединенные Штаты, 99216
- MultiCare Deaconess Cancer and Blood Specialty Center - Valley
-
Tacoma, Washington, Соединенные Штаты, 98405
- MultiCare Tacoma General Hospital
-
Vancouver, Washington, Соединенные Штаты, 98664
- PeaceHealth Southwest Medical Center
-
Walla Walla, Washington, Соединенные Штаты, 99362
- Providence Saint Mary Regional Cancer Center
-
Yelm, Washington, Соединенные Штаты, 98597
- Providence Regional Cancer System-Yelm
-
-
Wisconsin
-
Eau Claire, Wisconsin, Соединенные Штаты, 54701
- Marshfield Medical Center-EC Cancer Center
-
Marshfield, Wisconsin, Соединенные Штаты, 54449
- Marshfield Medical Center-Marshfield
-
Milwaukee, Wisconsin, Соединенные Штаты, 53226
- Medical College of Wisconsin
-
Minocqua, Wisconsin, Соединенные Штаты, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Соединенные Штаты, 53149
- ProHealth D N Greenwald Center
-
New Richmond, Wisconsin, Соединенные Штаты, 54017
- Cancer Center of Western Wisconsin
-
Oconomowoc, Wisconsin, Соединенные Штаты, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Rice Lake, Wisconsin, Соединенные Штаты, 54868
- Marshfield Medical Center-Rice Lake
-
Stevens Point, Wisconsin, Соединенные Штаты, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Waukesha, Wisconsin, Соединенные Штаты, 53188
- UW Cancer Center at ProHealth Care
-
Waukesha, Wisconsin, Соединенные Штаты, 53188
- ProHealth Waukesha Memorial Hospital
-
Weston, Wisconsin, Соединенные Штаты, 54476
- Marshfield Medical Center - Weston
-
-
Wyoming
-
Cheyenne, Wyoming, Соединенные Штаты, 82001
- Cheyenne Regional Medical Center-West
-
Cody, Wyoming, Соединенные Штаты, 82414
- Billings Clinic-Cody
-
Sheridan, Wyoming, Соединенные Штаты, 82801
- Welch Cancer Center
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
-
High grade Ta, T1 or CIS urothelial carcinoma. Accrual of patients with Ta or T1 disease may be closed to ensure adequate patients enrollment to meet the primary endpoint
-
Persistent disease (defined as not achieving disease free status) after completing therapy with at least induction BCG (>= 5 doses) and the first round of maintenance or second induction course (>= 2 doses). The subsequent round of BCG, either maintenance or repeat induction, must be given within 6 months of initial induction BCG
-
Persistent high risk NMIBC (T1, high grade Ta and/or CIS) must be within 9 months of the last BCG instillation despite having received adequate BCG as defined above.
- Registration must be within 12 months of last BCG instillation
-
High grade T1 after completing therapy with at least induction BCG (>= 5 doses) or after completing therapy with at least induction BCG (>= 5 doses) and first round of maintenance or second induction course (>= 2 doses). The subsequent round of BCG, either maintenance or repeat induction, must be given within 6 months of initial induction BCG
- Disease recurrence (T1) must be within 9 months of the last BCG instillation despite having received adequate BCG as defined above
- Registration must be within 12 months of last BCG instillation
-
Mixed variant histology (adenocarcinoma, squamous cell carcinoma) is eligible, but pure variant histology is ineligible
-
Patients who are disease free at 6 months after starting BCG but have high grade recurrence (T1, Ta, CIS) while on maintenance therapy would be eligible
- The recurrence must be within 6 months of the last BCG dose.
- Registration must be within 12 months of last maintenance BCG instillation
-
Patients must be deemed unfit for radical cystectomy by the treating physician or refuse radical cystectomy
-
All patients must have histologically confirmed urothelial cancer of the bladder within 60 days prior to registration
-
All visible tumor must be completely resected 60 days prior to registration (residual pure CIS is permitted)
- All patients must have had a cystoscopy (or TURBT with complete resection) without papillary tumor and negative urinary cytology within 28 days of registration (positive cytology is allowed in patients with CIS)
-
All patients with T1 tumors must undergo a re-staging transurethral resection of bladder tumor (TURBT) within 60 days of registration
- There must be uninvolved muscularis propria present in the re-staging TURBT. The initial TURBT prior to re-staging TURBT may be greater than 60 days prior to registration
-
Patients must have had imaging with CT or MRI abdomen/pelvis within 90 days of registration demonstrating no evidence of metastasis
-
Patients cannot have had a history of urothelial carcinoma in the ureters or prostatic urethra 24 months prior to registration
-
Patients must not be currently participating in or have participated in a study of an investigational agent or have used an investigational device within 4 weeks prior to study registration
- Note: Participants who have entered the follow-up phase of an investigational study may participate as long as it has been more than 4 weeks after the last dose of the previous investigational agent at time of registration
-
Patients must not have prior therapy with an anti-PD-1, anti-PD-L1, or anti PD L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor (e.g., CTLA-4, OX 40, CD137)
-
Patients must not have undergone prior allogeneic hematopoietic stem cell transplantation within the last 5 years prior to registration. (Participants who have had a transplant greater than 5 years ago are eligible as long as there are no symptoms of graft versus host disease [GVHD])
-
Patients must not have received prior systemic anti-cancer therapy including investigational agents within 4 weeks prior to treatment
- Note: Participants must have recovered from all adverse events (AEs) due to previous therapies to =< grade 1 or baseline. Participants with =< grade 2 neuropathy may be eligible
- Note: If participant received major surgery, they must have recovered adequately from the toxicity and/or complications from the intervention prior to starting study treatment
-
Patients must not have received prior radiotherapy within 2 weeks of study registration. Participants must have recovered from all radiation-related toxicities, not require corticosteroids, and not have had radiation pneumonitis
-
Patients must not have received radiation therapy to the lung that is > 30 Gy within 6 months prior to trial registration
-
Not pregnant and not nursing, because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects
- Women and men of reproductive potential should agree to use an appropriate method of birth control throughout their participation in this study due to the teratogenic potential of the therapy utilized in this trial. Include as applicable: Appropriate methods of birth control include abstinence, oral contraceptives, implantable hormonal contraceptives or double barrier method (diaphragm plus condom)
- A woman of childbearing potential (WOCBP) must not have a positive urine pregnancy test within 7 days prior to registration. If the urine test is positive or cannot be confirmed as negative, a serum pregnancy test will be required
- Patients must not be pregnant or breastfeeding or expecting to conceive or father children within the projected duration of the study, starting with registration through the last dose of treatment
-
Age >= 18 years
-
Eastern Cooperative Oncology Group (ECOG) performance status 0-2
-
Absolute neutrophil count (ANC) >= 1,500/mm^3
-
Platelet count >= 100,000/mm^3
-
Hemoglobin >= 9.0 g/dL
-
Creatinine =< 1.5 x upper limit of normal (ULN)
- In patients with creatinine > 1.5 x ULN, if measured or calculated creatinine clearance > 30 mL/min, then patient is eligible
-
Total bilirubin =< 1.5 x ULN
- In patients with a total bilirubin > 1.5 x ULN, if direct bilirubin < 1.0 X ULN, then patient is eligible
-
Aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) =< 2.5 x ULN
-
Patients must not have had an active autoimmune disease requiring systemic treatment within 24 months prior to registration. Autoimmune diseases include, but not limited to, lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis
-
Patients must not have a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to registration
- Note: Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) is not considered a form of systemic treatment and is allowed
-
Patients must not have a known psychiatric or substance abuse disorder that would interfere with the participant's ability to cooperate with the requirements of the study
-
Patients must not have active tuberculosis
-
Patients must not have been treated with antibiotics for an active infection within 14 days prior to registration. Prophylactic antibiotics are permitted. Treatment for a urinary tract infection (UTI) is allowed but must be deemed adequately treated by the treating physician prior the start of cycle 1 (C1) day 1 (D1)
-
Patients must not have a history of idiopathic pulmonary fibrosis or organizing pneumonia
-
Patients must not have a history of (non-infectious) pneumonitis that required steroids or have current pneumonitis
-
Patients with human immunodeficiency virus (HIV) are eligible with the following:
- On effective anti-retroviral therapy with undetectable viral load within 6 months of registration
-
HIV-infected participants must not have a history of Kaposi sarcoma and/or multicentric Castleman disease
-
Patients must not have a known additional malignancy that has had progression or has required active treatment in the last three years. Exceptions include basal or squamous cell carcinoma of the skin that has undergone potentially curative therapy or in situ cervical cancer. A history of prostate cancer that was treated with definitive intent is allowed, provided that the prostate-specific antigen (PSA) is undetectable for at least 1 year while off androgen deprivation therapy
-
Patients must not have known active CNS metastases and/or carcinomatous meningitis. Participants with previously treated brain metastases may participate provided they are radiologically stable, i.e., without evidence of progression for at least 4 weeks by repeat imaging (note that the repeat imaging should be performed during study screening), clinically stable and without requirement of steroid treatment for at least 14 days prior to first dose of study treatment
-
Patients must not have severe hypersensitivity (>= grade 3) to pembrolizumab and/or any of its excipients
-
Patients must not have an active infection requiring systemic therapy
-
Patients must not have a known history of hepatitis B (defined as hepatitis B surface antigen [HBsAg] reactive) or known active hepatitis C virus (defined as hepatitis C virus [HCV] ribonucleic acid [RNA] [qualitative] is detected) infection
- Note: No testing for hepatitis B and hepatitis C is required unless mandated by a local health authority
-
Patients must not have received live vaccines within 30 days of study drug administration. Examples of live vaccines include, but are not limited to, the following: measles, mumps, rubella, varicella/zoster (chicken pox), yellow fever, rabies, Bacillus Calmette-Guerin (BCG), and typhoid vaccine. Seasonal influenza vaccines for injection are generally killed virus vaccines and are allowed; however, intranasal influenza vaccines (e.g., FluMist®) are live attenuated vaccines and are not allowed. COVID-19 vaccinations are permitted
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Н/Д
- Интервенционная модель: Одногрупповое задание
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Treatment (pembrolizumab, gemcitabine hydrochloride)
INDUCTION: Patients receive pembrolizumab IV over 25-40 minutes on day 1 of cycles 1-4. Patients also receive gemcitabine hydrochloride intravesically on days 1, 8 and 15 of cycles 1 and 2. Treatment repeats every 3 weeks for 4 cycles in the absence of disease progression or unacceptable toxicity. MAINTENANCE: Beginning cycle 5, patients with no evidence of disease after induction receive pembrolizumab IV over 25-40 minutes and gemcitabine intravesically on day 1 of each cycle. Treatment repeats every 3 weeks for 12 cycles in the absence of disease progression or unacceptable toxicity. Additionally, patients with T1 tumors undergo a re-staging TURBT within 60 days of registration. Patients also undergo urine and blood sample collection, bladder biopsy, cystoscopy, CT and MRI throughout the study. |
Undergo CT
Другие имена:
Undergo MRI
Другие имена:
Given IV
Другие имена:
Undergo TURBT
Другие имена:
Undergo cystoscopy
Другие имена:
Undergo urine and blood sample collection
Другие имена:
Undergo bladder biopsy
Другие имена:
Given intravesically
Другие имена:
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Complete response rate in the carcinoma in situ (CIS) subpopulation
Временное ограничение: At 6 months (end of cycle 8, week 25)
|
A complete response, only for patients with a CIS component, is a cystoscopy without evidence of bladder tumor and negative biopsy (including directed biopsies to any suspicious areas and in addition random bladder biopsies including trigone, left lateral wall, right lateral wall, posterior bladder, dome of bladder, and the prostatic urethra in men), and negative cytology for high grade disease. |
At 6 months (end of cycle 8, week 25)
|
|
Event-free survival at 18 months
Временное ограничение: From the date of study registration to the first documentation of an event or death whichever comes first, assessed up to 18 months
|
For patients without a documented event and who are still alive, they will be censored at last disease assessment. For patients who start any subsequent ant-cancer therapy without any reported events will be censored at their last disease assessment. will be obtained with a Kaplan-Meier estimator (using the Greenwood formula to estimate the variance) for the entire 153 patient group consisting of patients with CIS, CIS with Ta/T1 or Ta or T1 disease. A 90% confidence interval will be generated for the 18-month EFS estimate. |
From the date of study registration to the first documentation of an event or death whichever comes first, assessed up to 18 months
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Incidence of adverse events
Временное ограничение: Up to 5 years post treatment
|
Adverse events will be assessed based on the National Cancer Institute common toxicity criteria (Common Terminology Criteria for Adverse Events version 5.0). |
Up to 5 years post treatment
|
|
Duration of response (DOR)
Временное ограничение: From the time a patient had a documented response (the time would start at the time a response was first noted) until disease-progression, assessed up to 5 years
|
Analysis will only include those patients in the CIS population who achieve a response. Patients who are alive and without a documented progression at the time of analysis will be censored at the time of the last disease status evaluation. The Kaplan-Meier product-limit estimator will be used to estimate DOR, medians and 95% confidence intervals (CI). |
From the time a patient had a documented response (the time would start at the time a response was first noted) until disease-progression, assessed up to 5 years
|
|
Progression-free survival (PFS)
Временное ограничение: From the date of study registration to the date of progression or death due to any cause, whichever occurs first, assessed up to 5 years
|
Surviving patients without any documented progressions will be censored at the date of last known contact. Progression will be defined as the development of muscle invasive bladder cancer or metastatic urothelial cancer (nodal and/or distant). The Kaplan-Meier product-limit estimator will be used to estimate PFS, medians and 95% CI. |
From the date of study registration to the date of progression or death due to any cause, whichever occurs first, assessed up to 5 years
|
|
Overall survival (OS)
Временное ограничение: From the date of study registration to date of death due to any cause, assessed up to 5 years
|
Surviving patients will be censored at the date of last known contact. The Kaplan-Meier product-limit estimator will be used to estimate OS, medians and 95% CI. |
From the date of study registration to date of death due to any cause, assessed up to 5 years
|
|
Cystectomy-free survival
Временное ограничение: From the date of study registration to the date of cystectomy for all patients
|
The Kaplan-Meier product-limit estimator will be used to estimate cystectomy-free survival, medians and 95% CI. |
From the date of study registration to the date of cystectomy for all patients
|
|
Recurrence free survival (RFS)
Временное ограничение: From the date of study registration to the first documentation of recurrence or death due to any cause, assessed up to 5 years
|
Surviving patients without any documented recurrence will be censored at the date of last known contact. Recurrence will be defined as the development of high-grade bladder cancer for patients with a CIS component only and those without a CIS component. The Kaplan-Meier product-limit estimator will be used to estimate RFS, medians and 95% CI. |
From the date of study registration to the first documentation of recurrence or death due to any cause, assessed up to 5 years
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Michael E Woods, Alliance for Clinical Trials in Oncology
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
- Урогенитальные заболевания
- Урогенитальные новообразования
- Новообразования по локализации
- Новообразования
- Мужские мочеполовые заболевания
- Урологические заболевания
- Женские урогенитальные заболевания
- Женские мочеполовые заболевания и осложнения беременности
- Урологические новообразования
- Заболевания мочевого пузыря
- Новообразования мочевого пузыря
- Гетероциклические соединения, 1-кольцо
- Гетероциклические соединения
- Следственные методы
- Клинические лабораторные методы
- Диагностические методы и процедуры
- Диагноз
- Хирургические процедуры, оперативные
- Минимально инвазивные хирургические процедуры
- Цитологические методы
- Цитодиагностика
- Дезоксицитидин
- Цитидин
- Пиримидиновые нуклеозиды
- Пиримидины
- Диагностические методы, хирургический
- Эндоскопия
- Химические методы, аналитические
- Анализ спектра
- Урологические хирургические процедуры
- Урогенитальные хирургические процедуры
- Диагностические методы, урологические
- Гемцитабин
- Биопсия
- Обработка образца
- Пембролизумаб
- Магнитно -резонансная спектроскопия
- Трантуретральная резекция мочевого пузыря
- Цистоскопия
Другие идентификационные номера исследования
- NCI-2019-07573
- U10CA180821 (Грант/контракт NIH США)
- NCI-2019-07573 (Идентификатор реестра: CTRP (Clinical Trial Reporting Program))
- A031803 (Другой идентификатор: CTEP)
- A031803 (Другой идентификатор: Alliance for Clinical Trials in Oncology)
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Описание плана IPD
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .